tenk.fyi

Jasper Therapeutics, Inc.

JSPRNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$75.8M

6.4% YoY

EPS

$-3.95

19.2% YoY

Cash

$28.7M

59.9% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro